Center for Research Strategy
Stored: Center for Research Strategy
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
Center for Research Strategy (CRS) is an office within the National Cancer Institute (NCI), established to enhance strategic planning and analysis for NCI’s $7.2 billion annual research enterprise, located at NCI’s Shady Grove campus in Rockville, Maryland. Operating within the Office of the Director, CRS conducts data-driven evaluations, manages the NCI Professional Judgment Budget, and collaborates across NIH and external stakeholders to shape cancer research priorities, assess portfolio impacts, and respond to congressional inquiries, supporting NCI’s mission to advance cancer science and public health.
Mission
The Center for Research Strategy aims to drive NCI’s scientific agenda by providing analytical expertise, strategic planning, and evaluation tools to optimize resource allocation and research outcomes. It supports NCI leadership with evidence-based insights, fosters cross-cutting initiatives, and communicates cancer research impacts to policymakers and the public.
Parent organization
The Center for Research Strategy operates under the National Cancer Institute, the federal leader in cancer research, within the National Institutes of Health, part of the Department of Health and Human Services.
Legislation
CRS was not created by specific legislation but functions under NCI’s authority from the National Cancer Act of 1937, expanded by the National Cancer Act of 1971, enabling strategic research planning.
Partners
CRS collaborates with:
- NCI Divisions, Offices, and Centers for internal analysis
- NIH institutes for cross-agency initiatives
- U.S. Congress and federal agencies for policy and budget support
Number of employees
CRS’s exact staff size is not publicly detailed; it operates with a small team of analysts and planners within NCI’s Office of the Director, supporting NCI’s broader 6,000+ workforce.
Organization structure
CRS is structured within NCI’s Office of the Director:
- Strategic Planning Team develops NCI’s research agenda.
- Portfolio Analysis Team evaluates funding impacts.
- Science Evaluation Team assesses research progress.
Leader
The Center for Research Strategy is headed by a Director; the current leader is not specified in recent public records.
Divisions
The divisions include:
- Strategic Planning for NCI budget and priorities.
- Portfolio Analysis for grant and research impact assessment.
- Science Evaluation for monitoring NCI research progress.
List of programs
CRS oversees:
- NCI Professional Judgment Budget - https://www.cancer.gov/about-nci/budget/professional-judgment-budget-proposal
- Research Portfolio Analysis
- Science Planning Workshops
Last total enacted budget
CRS’s budget is not separately itemized; it’s part of NCI’s $7.2 billion FY 2025 request, with no specific allocation disclosed.
Staff
CRS employs a small, unspecified team of scientific planners and analysts, leveraging NCI’s ~6,000 staff for broader support.
Funding
CRS is funded through NCI’s budget via NIH appropriations, supporting its planning and analysis activities without independent revenue.
Services provided
CRS provides strategic planning, portfolio analysis, science evaluation, and policy support, including NCI’s Professional Judgment Budget and congressional responses.
Regulations overseen
CRS does not oversee regulations but operates under NIH policies and federal grant rules (e.g., 45 CFR Part 75).
Headquarters address
The headquarters address, as listed on Google Maps, is 9609 Medical Center Drive, Rockville, MD 20850, USA, within NCI’s Shady Grove campus.
History
CRS evolved post-1971 National Cancer Act as NCI formalized strategic planning, gaining prominence with data-driven initiatives like the Professional Judgment Budget, aligning with NCI’s modern research management needs.
